Le Lézard
Classified in: Health
Subjects: CCA, MAT

Trulieve Cannabis Corp. Announces Release Date, Conference Call and Webcast for the Third Quarter of 2020


TORONTO, Oct. 13, 2020 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States, will release its third quarter 2020 financial results on Tuesday, November 17, 2020, before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 9836737. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until November 24, 2020. To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 9836737.

A live audio webcast of the conference call will be available at: http://bit.ly/trulq32020.

Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. An archived replay of the webcast will be available for 90 days by clicking the link above.

About Trulieve

Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

To learn more about Trulieve, visit www.Trulieve.com.

The Canadian Securities Exchange has not reviewed, approved or disapproved the ?content of this news release.?

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

at 20:48
The final 2021 Medicare Physician Fee Schedule (MPFS) issued today by the Centers for Medicare & Medicaid Services (CMS) failed to provide relief from a significant shift in physician and non-physician payments expected to take effect on January 1,...

at 20:25
MIVI Neuroscience, Inc. announced that it has enrolled the first patient in the Food and Drug Administration approved Investigational Device Exemption EVAQ Clinical Study.  The procedure took place at Hôpital de Purpan in Toulouse, France.  The...

at 20:09
IsoPlexis, the leader in single-cell functional proteomics, announced today that the Single-Cell Intracellular Proteome Chip, its next-generation solution which characterizes protein signaling pathways of single cells for the accelerated development...

at 20:00
At Celebrating Women Center in Oxnard, California, Dr. Adrienne Lara, MD, wants her patients to know that she went to medical school for you. She believes good patient care is collaborative and involves both the patient and doctor working together as...

at 20:00
Dr. Katherine Lorenzo Sirage is a general and cosmetic dentist and owner of Mirage Dental Arts in Miami, Florida. She is fluent in both English and Spanish. Her state of the art dental office uses the most advanced digital technology to provide the...

at 19:45
Ufovax, LLC, (Ufovax), a vaccine biotechnology company based on the Single-component Self-Assembling protein NanoParticle (1c-SApNP) vaccine design and manufacturing platform invented by Associate Professor Jiang Zhu, PhD, of Scripps Research (La...



News published on 13 october 2020 at 17:48 and distributed by: